secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2025-07-14T23:59:59+00:00
Accession:  0001654954-25-008035
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zivo Bioscience raises $250k initial tranche in $2M convertible debt offering
-----------------------------------------------------------------------------

- Issued $250k bridge promissory note with 10% annual interest, compounded annually; due after 2 years or upon $5M+ equity financing.
- Note converts at lower of issuance price or 80% of qualified financing share price; prepayment allowed at 115% of principal.
- Accompanying warrant to purchase 1,793 shares at issuance closing price, 5-year term, immediately exercisable.
- Total offering up to $2M; proceeds for general operations; notes unsecured and junior to secured debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495425008035/0001654954-25-008035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495425008035/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-008035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer